Temporal Gut Microbial Changes Predict Recurrent Clostridiodes Difficile Infection in Patients With and Without Ulcerative Colitis

被引:16
作者
Lee, Allen A. [1 ]
Rao, Krishna [2 ]
Limsrivilai, Julajak [3 ]
Gillilland, Merritt [1 ]
Malamet, Benjamin [4 ]
Briggs, Emily [1 ]
Young, Vincent B. [2 ,5 ]
Higgins, Peter D. R. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Div Infect Dis, Ann Arbor, MI USA
[3] Mahidol Univ, Siriraj Hosp, Dept Internal Med, Div Gastroenterol, Bangkok, Thailand
[4] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA
[5] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA
关键词
gut microbiota; predictive modeling; Clostridiodes difficile infection; ulcerative colitis; Lasso regression; INFLAMMATORY-BOWEL-DISEASE; EPIDEMIOLOGY;
D O I
10.1093/ibd/izz335
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Ulcerative colitis (UC) carries an increased risk of primary and recurrent Clostridiodes difficile infection (rCDI), and CDI is associated with UC flares. We hypothesized that specific fecal microbial changes associate with UC flare and rCDI. Methods: We conducted a prospective observational cohort study of 57 patients with (IC and CDI, CDI only, and UC only. Stool samples were collected at baseline, at the end of antibiotic therapy, and after reconstitution for 16S rRNA sequencing. The primary outcomes were recurrent UC flare and rCDI. Logistic regression and Lasso models were constructed for analysis. Results: There were 21 (45.7%) patients with rCDI, whereas 11 (34.4%) developed UC flare. Patients with rCDI demonstrated significant interindividual (P = 0.008) and intraindividual differences (P = 0.004) in community structure by Jensen-Shannon distance (JSD) compared with non-rCDI. Two cross-validated Lasso regression models predicted risk of rCDI: a baseline model with female gender, hospitalization for UC in the past year, increased Ruminococcaceae and Verrucomicrobia, and decreased Eubacteriaceae, Enterobacteriaceae, Lachnospiraceae, and Veillonellaceae (AuROC, 0.94); and a model 14 days after completion of antibiotics with female gender, increased Shannon diversity, Ruminococcaceae and Enterobacteriaceae, and decreased community richness and Faecalibacterium (AuROC, 0.9). Adding JSD between baseline and post-treatment samples to the latter model improved fit (AuROC, 0.94). A baseline model including UC hospitalization in the past year and increased Bacteroidetes was associated with increased risk for UC flare (AuROC, 0.88). Conclusion: Fecal microbial features at baseline and after therapy predict rCDI risk in patients with and without UC. These results may help risk stratify patients to guide management.
引用
收藏
页码:1748 / 1758
页数:11
相关论文
共 39 条
  • [11] The Treatment-Naive Microbiome in New-Onset Crohn's Disease
    Gevers, Dirk
    Kugathasan, Subra
    Denson, Lee A.
    Vazquez-Baeza, Yoshiki
    Van Treuren, Will
    Ren, Boyu
    Schwager, Emma
    Knights, Dan
    Song, Se Jin
    Yassour, Moran
    Morgan, Xochitl C.
    Kostic, Aleksandar D.
    Luo, Chengwei
    Gonzalez, Antonio
    McDonald, Daniel
    Haberman, Yael
    Walters, Thomas
    Baker, Susan
    Rosh, Joel
    Stephens, Michael
    Heyman, Melvin
    Markowitz, James
    Baldassano, Robert
    Griffiths, Anne
    Sylvester, Francisco
    Mack, David
    Kim, Sandra
    Crandall, Wallace
    Hyams, Jeffrey
    Huttenhower, Curtis
    Knight, Rob
    Xavier, Ramnik J.
    [J]. CELL HOST & MICROBE, 2014, 15 (03) : 382 - 392
  • [12] The R Package geepack for Generalized Estimating Equations
    Halekoh, U
    Hojsgaard, S
    Yan, J
    [J]. JOURNAL OF STATISTICAL SOFTWARE, 2006, 15 (02): : 1 - 11
  • [13] Dynamics of the human gut microbiome in inflammatory bowel disease
    Halfvarson, Jonas
    Brislawn, Colin J.
    Lamendella, Regina
    Vazquez-Baeza, Yoshiki
    Walters, William A.
    Bramer, Lisa M.
    D'Amato, Mauro
    Bonfiglio, Ferdinando
    McDonald, Daniel
    Gonzalez, Antonio
    McClure, Erin E.
    Dunklebarger, Mitchell F.
    Knight, Rob
    Jansson, Janet K.
    [J]. NATURE MICROBIOLOGY, 2017, 2 (05):
  • [14] Review article: the role of butyrate on colonic function
    Hamer, H. M.
    Jonkers, D.
    Venema, K.
    Vanhoutvin, S.
    Troost, F. J.
    Brummer, R. -J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (02) : 104 - 119
  • [15] Recurrence Rate of Clostridium difficile Infection in Hospitalized Pediatric Patients with Inflammatory Bowel Disease
    Kelsen, Judith R.
    Kim, Jason
    Latta, Dan
    Smathers, Sarah
    McGowan, Karin L.
    Zaoutis, Theodore
    Mamula, Petar
    Baldassano, Robert N.
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 (01) : 50 - 55
  • [16] Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection
    Khanna, S.
    Montassier, E.
    Schmidt, B.
    Patel, R.
    Knights, D.
    Pardi, D. S.
    Kashyap, P. C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (07) : 715 - 727
  • [17] Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prevot 1938
    Lawson, Paul A.
    Citron, Diane M.
    Tyrrell, Kerin L.
    Finegold, Sydney M.
    [J]. ANAEROBE, 2016, 40 : 95 - 99
  • [18] Use of the Noninvasive Components of the Mayo Score to Assess Clinical Response in Ulcerative Colitis
    Lewis, James D.
    Chuai, Shaokun
    Nessel, Lisa
    Lichtenstein, Gary R.
    Aberra, Faten N.
    Ellenberg, Jonas H.
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : 1660 - 1666
  • [19] Rethinking gut microbiome residency and the Enterobacteriaceae in healthy human adults
    Martinson, Jonathan N., V
    Pinkham, Nicholas, V
    Peters, Garrett W.
    Cho, Hanbyul
    Heng, Jeremy
    Rauch, Mychiel
    Broadaway, Susan C.
    Walk, Seth T.
    [J]. ISME JOURNAL, 2019, 13 (09) : 2306 - 2318
  • [20] McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/cix1085, 10.1093/cid/ciy149]